SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-047237
Filing Date
2017-12-22
Accepted
2017-12-22 17:59:26
Documents
1
Period of Report
2017-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5884
  Complete submission text file 0001140361-17-047237.txt   7325
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Issuer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOPHARMX CORPORATION 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address
Hubbard Michael (Reporting) CIK: 0001633538 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37411 | Film No.: 171273407